Testosterone Lawsuits Continue to Progress, Reports Baron and Budd

Plaintiffs Allege Testosterone Drug Manufacturers Did Not Provide Sufficient Warnings of Potentially Dangerous Side Effects

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

DALLAS (PRWEB) May 30, 2014

Manufacturers of drugs used to provide treatment for low testosterone continue to face lawsuits from plaintiffs alleging the drug manufacturers failed to provide adequate warnings of potentially fatal side effects, reports the national law firm of Baron and Budd.

Testosterone therapy drugs have been linked to conditions such as stroke, blood clots, heart attack and other health issues. The lawsuits allege that manufacturers of these drugs did not provide sufficient warning of the risk of these health problems in either their advertising or labeling materials. Testosterone therapy drugs are designed to treat fatigue and low libido typically associated with aging.

The Public Library of Science published a study in January of 2014 showing a link between testosterone therapy drugs and cardiovascular problems (http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805). In the study, researchers stated that older men – as well as younger men with a pre-existing diagnosis of heart disease – have a substantially higher risk of suffering from myocardial infarction after beginning testosterone therapy. Despite that risk, according to the study, the use of testosterone therapy is increasing.

Several lawsuits are underway in various courts around the country. For example, two lawsuits have been filed in the Court of Common Pleas of Philadelphia County against Auxilium Pharmaceuticals, the maker of Testim. The plaintiff in the case alleges that he suffered a heart attack in 2012 after using Testim as well as AndroGel (Olivetti et al v. Auxilium Pharmaceuticals Inc. et al, Case No. 140303508).

Another lawsuit was filed in April 2014 alleging that Auxilium misrepresented through physician and consumer advertising that Testim was safe for its intended use (Rios et al v. Auxilium Pharmaceuticals Inc. et al, Case No. 140302537).

“An alarmingly high number of men, as well as their families, have suffered harm,” said Stephen Blackburn, attorney at the national law firm of Baron and Budd. “We believe these drug makers should be held accountable for their negligence.”

If you or a loved one has suffered serious health problems after using testosterone therapy drugs, such as AndroGel, Axiron, Fortesta, Testim, Striant and others. please contact the national law firm of Baron and Budd. Call 866-472-9108 or visit our website at http://baronandbudd.com/areas-of-practice/pharmaceuticals/testosterone-therapy/ to learn more about how to proceed if you are considering filing a testosterone therapy lawsuit.

ABOUT BARON AND BUDD
The law firm of Baron and Budd, with offices in Dallas, Baton Rouge, Austin and Los Angeles, is a nationally recognized law firm with over 35 years of “Protecting What’s Right” for people, communities and businesses harmed by negligence. Baron & Budd’s size and resources enable the firm to take on large and complex cases. The firm represents individuals, governmental and business entities in areas as diverse as water contamination, Gulf oil spill, Qui Tam, California Proposition 65 violations, unsafe drugs and medical devices, Chinese drywall, deceptive advertising, consumer financial fraud, securities fraud and asbestos cancers such as mesothelioma.


Contact